Diode laser in management of loss of taste sensation in patients with post-COVID syndrome: a randomized clinical trial

BMC Oral Health. 2023 May 6;23(1):263. doi: 10.1186/s12903-023-02952-w.

Abstract

Objective: Loss of taste (ageusia) is a symptom observed following recovery from COVID-19 infection. The loss of taste and smell sensation may negatively affect patients' quality of life (QoL). The present study aimed to evaluate the effectiveness of the Diode Laser in managing loss of taste sensation in patients with post-COVID syndrome versus the placebo.

Material and method: The study sample was 36 patients who complained of persistent loss of taste sensation following COVID-19. The patients were randomly assigned to one of the two groups according to the received treatment: Group I (laser treatment) and Group II (light treatment), with each patient receiving a diode laser treatment or placebo from the same operator. Taste sensation was subjectively measured after treatment for four weeks.

Results: The results demonstrated a significant difference between both groups regarding taste restoration after one month (p = 0.041), with Group II having a significantly higher percentage of cases 7 (38.9%) with partial taste restoration. In contrast, a significantly higher proportion of Group I 17 cases (94.4%) had complete taste restoration (p < 0.001).

Conclusion: The present study concluded that using a Diode laser 810 nm aided in a more rapid recovery from loss of taste dysfunction.

Keywords: Ageusia; COVID-19; Diode laser; Laser therapy; Low-level; Quality of life; Recovery of function; Taste disorder.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Ageusia*
  • COVID-19* / complications
  • Humans
  • Lasers, Semiconductor / therapeutic use
  • Olfaction Disorders*
  • Quality of Life
  • SARS-CoV-2
  • Smell
  • Taste
  • Taste Disorders / etiology